Navigation Links
Clinical Symptoms Enough to Switch Drug Regimens for HIV Patients
Date:4/24/2008

Study showed little difference in survival when compared to expensive lab tests

THURSDAY, April 24 (HealthDay News) -- Decisions on switching to a second-line series of drugs for HIV/AIDS patients who are failing the first-line regimen are often made on the basis of sophisticated and expensive lab tests.

But a new study shows that survival is only slightly affected if these decisions are based instead on the appearance of clinical symptoms.

Researchers still need to develop less expensive versions of laboratory tests currently used, but lack of test availability shouldn't affect access to highly effective drugs in poorer nations, said the authors of a study in this week's issue of The Lancet.

"I hope that the findings will reassure health policy makers and clinicians that they should continue to make every effort to widen access to ART and not allow any concerns over lack of laboratory monitoring to inhibit this," said study author Andrew Phillips, a professor of epidemiology at Royal Free and University Medical School in London.

The World Health Organization (WHO) recommends that, in lower-income areas, decisions regarding drug treatment for HIV be based on symptoms and, when available, CD4 cell count, rather than viral load.

With viral load, switches to second-line treatment occur when the viral load exceeds 500 copies per millileter.

CD4 cells are a type of immune system cell. Patients generally switch to the second-line drugs when CD4 counts in the blood drop 50 percent from their highest.

WHO-recommended first-line treatment consists of the antiretroviral drugs Zerit (stavudine), Epivir (lamivudine) and Viramune (nevirapine).

Using a computer simulation model to analyze how antiretroviral therapy influences HIV infection, the researchers compared survival rates, switch of second-line medication regimens and development of resistance for three different s
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Cancer researchers receive NIH grant to advance brain tumor therapies from lab to clinical trials
2. Versus Technology, Inc. Announces Collaboration with Cleveland Clinic to Create Clinical Patient Flow Model
3. Welchol(TM) Added to the American College of Endocrinology/American Association of Clinical Endocrinologists Road Maps to Achieve Glycemic Control in Patients with Type 2 Diabetes Mellitus
4. Precyse Solutions Launches Clinical Documentation Improvement Program to Assist Hospitals in Accelerating Revenues
5. Clinical guidelines for the manual titration of PAP in OSA patients published in JCSM
6. Sunesis Pharmaceuticals Presents Nonclinical Data on SNS-595 at the Annual Meeting of the American Association for Cancer Research
7. Siemens New Clinical Education Training Facility Opens Doors and Expands Offerings for Imaging Professionals
8. Allegro Diagnostics Announces Publication in Cancer Prevention Research of Prediction Model for Lung Cancer Diagnosis Integrating Clinical and Genomic Features
9. Clinical Trial Volunteers Uneasy About Some Financial Ties
10. Quintiles Ranks First in Pan-European Clinical Investigator Study
11. Rejuvasun(TM) With Omnilux(TM): Industry First to Feature FDA-Cleared, Clinically Proven Light Therapy Technology
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Clinical Symptoms Enough to Switch Drug Regimens for HIV Patients
(Date:12/25/2014)... December 26, 2014 The microscopy ... of 7.2% to reach $5,756.0 million by 2019. ... microscopy market. The electron microscopes product segment is ... forecast period. , Rising focus on nanotechnology, technological ... of the microscopy market. , Get Full Copy ...
(Date:12/25/2014)... The report “Nintedanib (Colorectal Cancer) ... on the current treatment landscape, unmet needs, current ... market. Stivarga is a drug which is used ... Boehringer Ingelheim is developing nintedanib (BIBF-1120), an orally ... CRC in the US, Europe, and Japan. The ...
(Date:12/25/2014)... months the trends for evening dresses shift and ... of the hottest styles in the next few months.” The ... 26 A-line sweetheart evening dresses, and announces the availability of ... trying our best to help a lady to show off ... prices, we provide discounted delivery costs to our customers worldwide. ...
(Date:12/25/2014)... Angeles, CA (PRWEB) December 25, 2014 The ... Dolcemaschio was created in honor of a true 9/11 ... at two film festivals including the 24 hours of Nuremberg ... Festival in Bangladesh. , Actress, screenwriter and director ... helped produce this film together with her husband, Gregory ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 Helen Harris’ ... in Woodland Hills, California after an 8 year battle ... on Christmas Eve evening in her home in Woodland ... metastatic breast cancer. , As the ... forty years, she pioneered and championed many of today's ...
Breaking Medicine News(10 mins):Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4
... , THURSDAY, Dec. 1 (HealthDay News) -- Posting ... processing plants on the Internet so it can be viewed ... report released Wednesday. The report is from the National ... advice on challenges facing the United States and the world. ...
... in the levels of two proteins involved in folding, ... destructive brain plaque found in Alzheimer,s disease, researchers report. ... specific positions to unleash their functions. When levels are ... normally dormant BACE1, a protein responsible for beta amyloid ...
... MD, a fourth-year resident in clinical and anatomic ... the highly coveted Resident Leadership Representative Award from ... demonstrating leadership and promoting ASCP membership and resident ... team led by Dr. Martin Kroll, won the ...
... (EGCG)a flavonoid found in green teainhibits the hepatitis C ... in the December issue of Hepatology , a ... Association for the Study of Liver Diseases, suggest that ... reinfection following liver transplantation. HCV infection can ...
... on chromosomes in human cervical cancer cells disrupts DNA ... and kills them more quickly, according to a study ... to like see their laboratory findings published in ... safer, more effective combination therapies for hard-to-treat pediatric brain ...
... December 1, 2011 -- Only 21 percent of surveyed medical ... when and when not to wash their hands in the ... issue of the American Journal of Infection Control , ... in Infection Control and Epidemiology. Three researchers from ...
Cached Medicine News:Health News:Diametric shift in 2 protein levels spurs Alzheimer's plaque accumulation 2Health News:Green tea flavonoid may prevent reinfection with hepatitis C virus following liver transplantation 2Health News:Cancer cells' DNA repair disrupted to increase radiation sensitivity 2Health News:Cancer cells' DNA repair disrupted to increase radiation sensitivity 3Health News:2 out of 3 medical students do not know when to wash their hands 2
(Date:12/24/2014)... 2014  Lockton Dunning Benefits, the ... the addition of Vice President Kim Foerster ... Pharmacy Consulting team, Excelsior Solutions. ... to the position.  Most recently, she worked as ... Specialty Pharmacy, where she has held various managerial ...
(Date:12/24/2014)... , Dec. 23, 2014  Medical Science Liaisons play ... key link between the medical device industry and key ... in the coming years as the device industry relies ... According to research by benchmarking firm, Best Practices, LLC, ... an important edge is by harnessing new technology to ...
(Date:12/22/2014)...   TRU-D SmartUVC LLC, producers of the ... today that the General Services Administration has awarded the ... This newly formed agreement will allow TRU-D ... purchasers, including Department of Veteran Affairs and Department of ... purchasing solutions for the Ebola effort in ...
Breaking Medicine Technology:Kim Foerster Joins Lockton Companies 2Role of Medical Science Liaisons Evolving in Medical Device Sector 2TRU-D SmartUVC LLC Awarded General Services Administration Contract to Expand Government Customer Base 2
... as New US Sales Manager -- CALIFORNIA, September 14, 2010 ... ... ... var first_result; // Results are keyed by longUrl, so we need to grab the first one. for ...
... NOVATO, Calif., Sept. 14 BioMarin Pharmaceutical Inc. (Nasdaq: ... Corporate and Business Development of BioMarin, will present a company ... York City on Tuesday, September 21, 2010 at 3:30 p.m. ... audio webcast of the conference call via the investor section ...
Cached Medicine Technology:Digitron Appoint Gerry Casillas as New US Sales Manager 2Digitron Appoint Gerry Casillas as New US Sales Manager 3Digitron Appoint Gerry Casillas as New US Sales Manager 4Digitron Appoint Gerry Casillas as New US Sales Manager 5Digitron Appoint Gerry Casillas as New US Sales Manager 6Digitron Appoint Gerry Casillas as New US Sales Manager 7BioMarin to Present at the UBS Global Life Sciences Conference 2
... most other EMR,systems require you ... is the only,electronic patient charting,solution ... orthopaedic,workflow. Created around,five specific criteria ... clinic,OrthoPad allows you to see,more ...
The Tag-It™ Cystic Fibrosis ASR reagents can be used by high complexity CLIA approved laboratories for detection of up to 70 mutations and 6 variants (polymorphisms) in the cystic fibrosis tran...
The Tag-It™ Cystic Fibrosis ASR reagents can be used by high complexity CLIA approved laboratories for detection of up to 70 mutations and 6 variants (polymorphisms) in the cystic fibrosis tran...
... EMS provides service to companies in many different ... and restaurants.There are no hidden charges at EMS ... and service are among the lowest in the ... of services ranging from MasterCard/Visa processing to Debit ...
Medicine Products: